Dried blood spot testing for the antenatal screening of HTLV, HIV, syphilis, toxoplasmosis and hepatitis B and C: prevalence, accuracy and operational aspects  by Boa-Sorte, Ney et al.
b r a z j i n f e c t d i s . 2 0 1 4;1  8(6):618–624
The Brazilian Journal of
INFECTIOUS  DISEASES
www.elsev ier .com/ locate /b j id
Original article
Dried  blood  spot  testing  for the antenatal  screening
of HTLV,  HIV,  syphilis,  toxoplasmosis  and  hepatitis
B and  C:  prevalence,  accuracy  and
operational aspects
Ney Boa-Sortea,b, Antônio Puriﬁcac¸ãoa,c, Tatiana Amorimd,∗, Lorena Assunc¸ãoa,
Alan Reis c,e, Bernardo Galvão-Castrob,f
a Associac¸ão de Pais e Amigos dos Excepcionais de Salvador – APAE Salvador, Salvador, BA, Brazil
b Escola Bahiana de Medicina e Saúde Pública, Salvador, BA, Brazil
c Secretaria Estadual de Saúde do Estado da Bahia – SESAB, Salvador, BA, Brazil
d Universidade do Estado da Bahia (UNEB), Salvador, BA, Brazil
e Secretaria Municipal de Saúde, Lauro de Freitas, BA, Brazil
f Laboratório Avanc¸ado de Saúde Pública, Centro de Pesquisas Gonc¸alo Moniz, Fundac¸ão Oswaldo Cruz (FIOCRUZ), Salvador, BA, Brazil
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 24 January 2014
Accepted  27 May 2014
Available  online 9 July 2014
Keywords:
Prenatal care
Infectious diseases
Seroprevalence
Dried  blood spot testing
a  b  s  t  r  a  c  t
Introduction: Screening for vertically transmitted infection is mandatory and must be con-
ducted  at the ﬁrst prenatal consultation. The most vulnerable women’s groups are those at
the lowest socio-economic level. Dried blood spot testing on ﬁlter paper could represent a
secure way to screen pregnant women in the prenatal period.
Methods:  A cross-sectional study was conducted between November 2009 and March 2010,
in  the Metropolitan Region of Salvador, Bahia, Brazil, to compare the accuracy of the dried
blood  spot in ﬁlter paper and venipuncture serological as screening methods for HIV, HTLV,
VHB, VHC, Treponema pallidum, and Toxoplasma gondii during prenatal period. Results of the
venous blood sample collected in tubes were considered the gold standard.
Results:  Serum samples and dried blood spot were obtained from 692 pregnant women aged
between  14 and 42 years, with a median age of 26. Thirteen women were  seropositive for
T.  gondii (1.88%; 95% CI: 0.60–2.71%), ﬁve for T. pallidum (0.72%; 95% CI: 0.15–1.61%), two for
HBV  (0.29%; 95% CI: 0.050.95%) and one for HTLV-1 (0.14%; 95% CI: 0.01–0.71%). No one waspositive  for HCV and HIV. The dried blood spot accuracy for syphilis and HTLV were  100%
(95%  CI: 99.25–100) and 100% (95% CI: 99.45–100%), respectively. The average time between
blood  collection and recording of the sample in the reference laboratory was  4.93 (3.82) days
and  between dried blood spot processing and active search for pregnant women was 3.44
(4.27)  days.
∗ Corresponding author at: Alameda Verona, 32, Pituba, CEP 41830-465, Brazil.
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Conclusions: The use of dried blood spot may represent a secure way to expedite access to
results of vertically transmitted diseases in the prenatal period, particularly in regions with
scarce healthcare resources.
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UBS,  Cidade Nova UBS, São Judas Tadeu UBS, Israel Moreira
UBS,  Outpatient’s Clinics in the Centre and in Caji-Vida Nova,
Irmã  Dulce UBS, Vila Nova UBS and Noel Alves da Cruz UBS.
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mplementation of the Prenatal and Birth Humanization Pro-
ramme  (Programa de Humanizac¸ão do Pré-Natal e do Nascimento:
HPN)  of the Brazilian Ministry of Health has established
bjective standards to assess the quality of prenatal care.1
hese criteria include the percentage of pregnant women who
ndergo anti-Human Immunodeﬁciency Virus (HIV) test and
yphilis  serology test in both the 1st and 3rd trimesters of
regnancy.1,2
In Brazil, serological screening for HIV in pregnant women
s  recommended and should be conducted at the ﬁrst prena-
al  consultation.3 However, weaknesses in healthcare network
rovision  of laboratory diagnosis, insufﬁcient coverage of
omen  tested in the prenatal period hinder adequate prophy-
axis  to approximately 50% of pregnant women  infected with
IV.3 This specially is the case for women  most vulnerable to
IV  such as sex workers, injecting drug users, and those of
ower  socio-economic strata,4 as a result of low quality of pre-
atal  care.5 Likewise, the same is observed for other infections
uch  as syphilis, hepatitis B and C and toxoplasmosis, causing
iseases  in pregnancy and fetal morbidity and mortality.2,5,6
iagnosis of human T-cell lymphotropic virus-type 1 (HTLV-1)
nfection  is also frequently missed despite being preva-
ent  in Brazil, predominantly in the North and Northeast
egions.7,8
Despite such recommendations, both the supply of and
ccess  to serology during the prenatal period remain highly
estricted.4,9 Furthermore, qualitative data state that two
actors  related to greater adherence to prenatal care are avail-
bility  of tests within primary healthcare units, associated
ith  good quality professional care.10 Thus, procedures that
ncrease  access to serologic diagnosis and guarantee that the
regnant  woman  receives her results within the required time
ust be implemented within the Network of Primary Health-
are  Units (Unidades da Rede Básica de Saúde: UBS) and at Family
ealth  Programme  (Programa de Saúde da Família: PSF) centers.
ried  blood spot testing on ﬁlter paper (DBS), as a vehicle for
he  storage and transportation of blood, has been proven suc-
essful in neonatal screening11 and has some advantages in
elation  to traditional plasma and serum samples, such as
ase  of collection, transportation and storage, room tempera-
ure  sample stability, and less risk of contamination.12
The use of DBS as a screening tool to detect HIV anti-
odies has occurred in epidemiological surveys since the
eginning  of the 1990s,13 and is considered an option in both
eveloping countries and remote regions where appropriate
aboratory support does not exist.12–14 In Brazil, this strategy
or  the identiﬁcation of infectious agents has been assessed
s  successful,15–18 including for prenatal screening.19–21Although several studies have demonstrated the accuracy
of  serological screening for HIV, HTLV and other infectious
agents when comparing DBS with plasma and serum,16,17 few
validation  studies have been conducted in the primary health-
care  network22,23 and no studies in our environment have
measured the operational time elapsed between blood collec-
tion  and availability of the result.
In this work we have assessed the prevalence of HIV,  HTLV,
VHB,  VHC, syphilis and toxoplasmosis in pregnant women;
the  accuracy of serological screening using DBS  compared
to  serum; and the time elapsed between blood collection,
laboratory processing and result availability at the primary
healthcare coordination department of the Unitary Health
System  (Sistema Único de Saúde: SUS) in the municipality of
Lauro  de Freitas, in the Metropolitan Region of Salvador, Bahia.
Materials  and  methods
Study  design  and  location
A cross-sectional study was  conducted between November
2009  and March 2010 to evaluate the accuracy of DSB compared
to  standard serological screening methods for HIV, HTLV, VHB,
VHC, Treponema pallidum (T. pallidum), and Toxoplasma gondii (T.
gondii).
The study was conducted in Lauro de Freitas, in the
Metropolitan Region of Salvador (Região Metropolitana de Sal-
vador:  RMS), the state capital of Bahia, in North East Brazil.
In  2010, this municipality had 163,449 inhabitants and, in
terms  of gross domestic product (GDP), was  ranked 25th in
the  North East region, with approximately 0.6% of the region’s
total  GDP. In 2009, 22.3% of the RMS population had private
health  insurance.a There were  84,173 (51.5%) female inhabi-
tants,  of which 57,854 were  of childbearing age (10–49 years
old),  accounting for 68.7% of the municipality’s female pop-
ulation,  with an average monthly income of R$1217.00 (US$
546.69),  with a ratio of 0.64 in relation to the average salary
of  men. In approximately 40% the household head were  the
women.
In  January 2010, the municipality had 16 Primary Health-
care  Units (UBS) distributed across seven administrative
sub-units. The following units were enrolled in the study:
Centre  for Women’s Health, Citizen’s Space, São Paulo Parka Data obtained from: http://tabnet.datasus.gov.br/CGI/tabcgi.
exe?idb2010/f16def (in Portuguese) [accessed 07.06.12].
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These units were  in locations that provide prenatal care or
offer  pregnant women  serological testing. The district of Areia
Branca was  not included because of its small representative
population, distance from the municipal center and since it
does not provide laboratory services related to the collection
of  biological material for serological testing.
Routines  for  healthcare  and  the  collection  of  biological
material
During the study period, all pregnant women  who sponta-
neously  attended the prenatal healthcare network and SUS’s
own-  and afﬁliated-laboratory networks in order to carry out
the  required prenatal care tests at the appropriate units were
invited  to take part. Following an explanation of the study
objectives, risks and expected beneﬁts and after signing the
Free  and Informed Consent Form, about 10 mL  of blood was
obtained  by venipuncture and approximately 9.0 mL  of the
material  was  packed in a drying tube, while the rest was
packed  on Schleicher & Schuell 903© ﬁlter paper in ﬁve circles
of  1.0 cm diameter.24 We did not collect a new ﬁlter paper sam-
ple  from the women  who had already conducted the serum
and  paper ﬁlter test during the study period, but followed the
prenatal  care routine, carrying out the VDRL test, as recom-
mended  by the Ministry of Health.9
The DBS sample was  identiﬁed through the woman’s name,
date  of birth and collection, date of last menstruation, ges-
tational  age, past obstetric history (number of pregnancies,
abortions and births) and healthcare unit of collection. All
the  drying, packing and storage procedures for the DBS paper
ﬁlters  were  conducted as previously described.22 At the end
of  the daily collections, the DBS and blood collection tubes
were  dispatched to the Central Laboratory (Laboratório Central:
LACEN)  of Lauro de Freitas to be stored in a refrigerator. In
addition,  we dispatched the DBS to the Neonatal Screening
Laboratory of the Association of Parents and Friends of Hand-
icapped  Children of Salvador (Associac¸ão de Pais e Amigos dos
Excepcionais  de Salvador: APAE Salvador) in accordance with the
municipal  administrative routine, previously instituted for the
“heel  prick test”.
Elapsed  time between collection and registration of the
sample  at APAE Salvador was  called sample retention time and
elapsed  time between arrival of the sample at the laboratory
and  release and immediate communication of the result to the
Municipal  Health Department (Secretaria Municipal de Saúde:
SMS)  was  called active search time. Specialized care for pregnant
woman  with HTLV was  available at the HTLV Centre at the
Bahian  School of Medicine and Public Health (Escola Bahiana
de  Medicina e Saúde Pública: EBMSP) and for the other women
tested  this was  available at the municipality’s reference units
for  the care of STDs/AIDS.
Laboratory  methods
The samples were  processed to detect anti-HIV 1+2, anti-
HTLV-1  and 2, anti-VHC antibodies, anti T. pallidum (IgM
and  IgG), anti-T. gondii IgM antibodies and HBsAg on ﬁlter
paper  and plasma using the enzyme linked immunosorbent
assay (ELISA). The immunological markers (antibodies) were
obtained  by an elution process, using a buffered solution 1 4;1  8(6):618–624
containing protein, detergent, stabilizers and 0.1% sodium
azide,  and then subjected to ELISA, as recommended by the
manufacturer. The serology tests were  blindly performed on
eluates obtained from the ﬁlter paper and serum at the Lab-
oratory  of the Centre for Diagnosis and Research (Laboratório
do  Centro de Diagnóstico e Pesquisa: CEDIP) of APAE Salvador,
according to its laboratory routine.
We used the following commercial kits on the material
obtained on ﬁlter paper.
IMUNOSCREEN  HIV 1+2 – SS©, IMUNOSCREEN HTLV I and II
–  SS©, IMUNOSCREEN ANTI-HCV – SS©, IMUNOSCREEN TOXO
IGM  – SS©, IMUNOSCREEN SÍFILIS – SS© and IMUNOSCREEN
HBSAG – SS©, produced by MBIOLOG Diagnósticos LTD, Con-
tagem,  MG,  Brazil,26 which, at the time of the study, was  the
only  manufacturer in our country that produced diagnostic
paper ﬁlter kits for the studied agents. We used the following
commercial kits for the samples obtained in serum: MUREX
HIV  I and II©, MUREX HTLV I and II©, MUREX ANTI-HCV©,
MUREX  ICE SYPHILIS©, BIOELISA TOXO IgM©, MUREX HBsAg©,
produced  by MUREX BIOTECH LIMITED, Dartford, Kent, United
Kingdom.
Statistical  analysis
The prevalence rates were calculated and the 95% conﬁdence
intervals (95% CI) reported for each surrogate marker of the
infections  studied. Sensitivity and speciﬁcity for each infec-
tion  marker were  computed with their respective 95% CI. A
database  was constructed in Epi Info for Windows© version
3.2.2  and calculations were  made using the OpenEpi pro-
gramme,  version 2.1.3.25 For continuous variables averages,
medians and standard deviations (SD) are reported.
Ethical  aspects
The study was  approved by the Research Ethics Committee
of  the Osvaldo Cruz Foundation (BA), protocol no. 84/2006. All
the pregnant women were informed of the set of infectious
agents being tested and authorized the collection of a greater
quantity  of blood than usual. Positive tests for women  using
the  ﬁlter paper test were conﬁrmed by the presence of anti-
bodies  speciﬁc to the infectious agents studied and the SMS
of  Lauro de Freitas was  informed through the Active Search
System,  in order to locate the woman and provide her with
the  appropriate therapeutic and preventative intervention.
Results
Samples of serum and DBS were  obtained from 692 pregnant
women  aged between 14 and 42 years, with an average (SD)
and  median age of 27.1 (8.43) and 26 years, respectively. The
average  (SD) and median gestational ages at the time of blood
collection  were 15.78 (7.23) and 15 weeks, respectively. Sero-
logy  was collected during the 1st (45%), 2nd (46.56%) and 3rd
(8.45%)  trimester of pregnancy. The reference units of the Cen-
tre  for Women’s Health and the Citizen Space carried out 30.6%
and  14.3% of the total tests, respectively.
None of the samples were  reagent for HCV and HIV on DBS
or  on serum tests. Thirteen pregnant women (1.88%; 95% CI:
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.60–2.71) presented with IgM serology reagent for T. gondii.
ive  pregnant women  (0.72%; 95% CI: 0.15–1.61) tested positive
or  T. pallidum, two for HBV (0.29%; 95% CI: 0.05–0.95), and one
or  HTLV (0.14%; 95% CI: 0.01–0.71).
The sensitivity and speciﬁcity of DBS serology compared to
erum  ELISA are described in Table 1. Accuracy between the
wo  serological procedures (DBS and serum) was  100% (95%
I:  99.25–100.0) for syphilis and 100% (95% CI: 99.45–100.0%)
or HTLV (with a sensitivity of 100.0%; 95% CI: 20.6–100.0 and
 speciﬁcity of 100%; 95% CI: 99.4–100.0).
Average time (SD) between DBS collection and sample reg-
stration  at APAE, Salvador was  4.93 (3.82) days and average
ime  (SD) between processing the DBS material and an active
earch  for the pregnant woman was  3.44 (4.27) days.
iscussion
he most prevalent positive serological markers of the infec-
ions  assessed in the studied pregnant women  were  for
oxoplasmosis and syphilis. No sample was  reagent for either
IV  or HCV. DBS serology demonstrated a good level of accu-
acy  compared to serum serology, and offered a probable
eduction in elapsed time between testing and the municipal
ealth  system becoming aware of the result.
The average age of the studied pregnant women (27.1 years)
as  similar with the average age of the 2,956 pregnant women
n  the municipality of Lauro de Freitas in 2010 (26.6 yearsb).
uring  the study period, 1183 prenatal consultations were
ecorded,c which represented a serological testing coverage
f  58.5% of consultations. Given that there was  more  than
ne  consultation per pregnant woman, and that the pregnant
omen  in the second and third trimester, 46.6% and 8.45%
espectively, did not undertake another DBS serological test
uring  the study period, we  obtained good coverage for those
omen  who sought prenatal laboratorial assistance. These
ndings,  associated with the fact that the tests were  con-
ucted  in all public health units in the municipality that
rovide  a laboratory collection service, suggest the appropriate
epresentativeness of the study.
Most pregnant women  had their serology tests in the
econd  trimester of pregnancy, similar to what Lima and col-
aborators  observed in Salvador, where 65% of the pregnant
omen  only underwent their ﬁrst serology tests during this
eriod  of pregnancy.5 These authors also reported the longer
ime  taken in HIV and syphilis laboratory screening for low-
ncome  pregnant women.5 Although we did not assess income
n  this study, access to laboratory tests has become more  dif-
cult  for low-income pregnant women, which reinforces the
eed  to provide diagnostic methods during prenatal consulta-
ions  that take place in UBS and Family Health Units (Unidades
e  Saúde Familiar: USFs).
b Data obtained from the DATASUS site:
ttp://tabnet.datasus.gov.br/cgi/tabcgi.exe?sinasc/cnv/pnvba.def
in Portuguese) [accessed 20.02.12].
c Data obtained from the DATASUS site:
ttp://tabnet.datasus.gov.br/cgi/tabcgi.exe?sia/cnv/qaba.def (in
ortuguese) [accessed 08.06.12].4;1 8(6):618–624  621
The main problem related to late collection of serological
tests in prenatal care (PNC) refers to delays in the initiation of
prophylactic  measures for vertical transmission of HIV and the
immediate  treatment of syphilis.3 According to the Ministry
of  Health, antiretroviral therapy should be initiated from the
14th  week of gestation on.3 Data related to pregnant women
in  Salvador conﬁrm the late initiation of PNC and the difﬁ-
culty  of conducting serological tests for HIV and VDRL during
pregnancy.5
This study found a speciﬁc syphilis prevalence of 0.72%
(95%  CI: 0.15–1.61). A previous study of 1024 pregnant women,
conducted in Salvador at the beginning of the 1990s, found a
prevalence of 3.91% (95% CI: 2.72–5.09).26 In 2007 in the state of
Sergipe,  North East Brazil, a prevalence of 0.9% for syphilis was
described  in 9051 pregnant women.20 Over the last ﬁve years
in  Brazil, similar results have been observed in Mato Grosso,21
in the Central West region, and Botucatu (SP state),27 South
East  region. Greater prevalence has been observed in Vito-
ria  (ES), South East,28 and Londrina (PR) South,29 at 3.6% and
1.6%  respectively. Although the prevalence of syphilis among
pregnant  women varies across different regions of Brazil and
between  studies, the presence of this infection during preg-
nancy  continues to be an important public health problem
for  the country6 and is associated with the maintenance of
a  signiﬁcant incidence of congenital syphilis.
The HTLV-1 prevalence observed in the pregnant women
we  assessed was  less than the 2.0% described in general
female population of Salvador city in 1998,30 and in other stud-
ies  among pregnant women in Salvador, where the prevalence
has  ranged from 0.84 to 0.98%,26,31 but similar to that observed
in  the Central West18,19,21,32 and South East27 of Brazil. How-
ever, more  recently, the prevalence of the HTLV-1 infection in
blood donors in Salvador fell from 1.35% in 19937 to 0.48% in
2005,33 a fact also found in the rest of Brazil.8
The reduction in syphilis and HTLV-1 prevalence observed
in  the pregnant women in the present study, as well as in more
recent  studies, as opposed to previous studies conducted in
Salvador,  may  be due to the effect of HIV prevention cam-
paigns  and the enlarged support network for the diagnosis and
prevention  of STDs.33 These activities have had repercussions
on  primary prevention measures and on enhanced diagnostic
knowledge, which implies a reduction in the transmission of
these  agents.
On  the other hand, since there is a greater geographi-
cal proximity between Salvador and Lauro de Freitas, the
prevalence differences between the two cities were  unex-
pected.  This ﬁnding may  be partially explained by the
different assessment periods, since our study is more
recent, and therefore able to capture a prevalence reduc-
tion  among pregnant women as already observed in blood
donors7,8,26,33 and women  aged 16–30 years old, which is
the  age of most of the pregnant women studied, and also
given  that HTLV-1 infection increases with age.30 The per
capita  income difference found between the municipalities of
Lauro  de Freitas and Salvador (R$17,026.64/US$ 9922.28 versus
R$10,948.50/US$6380.24d) may  also justify these differences,
d Data obtained from the website of the Brazilian Institute of
Geography  and Statistics (Instituto Brasileiro de Geograﬁa e
622  b r a z j i n f e c t d i s . 2 0 1 4;1  8(6):618–624
Table 1 – Comparative accuracy between dried blood spots on ﬁlter paper and venous blood samples collected in tubes
for laboratory use to validate a collection and serological screening method for HIV, HTLV, HBV, HCV, Treponema pallidum
and Toxoplasma gondii in pregnant women, Lauro de Freitas, Bahia, 2009–2010.
Parameters Agent serology
HTLV HBV Treponema
palliduma
Toxoplasma
gondiia
HCV HIV
Sensitivity (%)
(95%  CI)
100.0
(20.6–100)
100.0
(34.2–100)
100.0
(43.8–100)
92.3
(66.7–98.6)
NEb NEb
Speciﬁcity (%)
(95%  CI)
100
(99.4–100)
100
(99.4–100)
100
(99.2–100)
99.9
(99.2–100)
100
(99.3–100)
100
(99.3–100)
Diagnostic accuracy (%)
(95%  CI)
100
(99.4–100)
100
(99.4–100)
100
(99.3–100)
99.7
(98.9–99.9)
100
(99.3–100)
100
(99.3–100)
a IgM reagent.
b NE, not evaluated.
since HTLV-1 has been associated with lower income and less
schooling.30
The other infectious agent found among these pregnant
women  was  HBV, at a prevalence of 0.29% (95% CI: 0.05–0.95).
These  values were  lower than those found in other Brazilian
studies,  including in the city of Salvador21,28,29,34,35 and inter-
national surveys in developing and low-income countries.36–38
Despite this, the prevalence of HBsAg was  higher among the
women  studied than that of HIV and HCV, for which we
did  not ﬁnd any seropositive woman, a ﬁnding repeated in
most  other federal units.21,30 However, HIV infection among
pregnant Brazilian women  was  described in another study
(seroprevalence 0.2%).39
The prevalence of anti-Toxoplasma IgM, suggestive of an
acute  infection, was  the most frequent among these pregnant
women,  reaching 1.88% (95% CI: 0.6–2.71). These ﬁndings are
similar  to those from other regions, which range from 0.4 to
2.1%.20,21,27,40 Although this result indicates a possible acute T.
gondii  infection, its prevalence was  lower than that observed
in  Salvador in the 1990s,26 which may  reﬂect a reduction
in acute infection during pregnancy as a result of the pop-
ulation’s  enhanced knowledge about exposure to infectious
agents.
This  study also assessed the possibility of the use of DBS as
a  tool for carrying out tests to detect antibodies against HIV,
HTLV,  HVB, HVC, T. pallidum and T. gondii through comparison
with  the same immune-trial conducted using serum. In par-
ticular,  this study used the cross-sectional method, which is
preferable to case–control studies, since the latter are subject
to  measurement bias of the predictor variable.41 By utilizing
a  cross-sectional method based on a pre-existing sample col-
lection  procedure for PNC serological screening in units that
routinely  carry out such tests, the study reproduces the clini-
cal  spectrum of disease incidence with respect to the capacity
of  the health system’s structural network to detect such an
event.
Estatística: IBGE)
http://www.ibge.gov.br/cidadesat/topwindow.htm?1 (in
Portuguese) and
http://www.ibge.gov.br/cidadesat/topwindow.htm?2 (in
Portuguese) [accessed 20.02.12 and 07.06.12].The diagnostic accuracy observed in this study was  similar
to  that described in other studies conducted in Brazil21–23 and
other  countries,12,13,42 and corroborates the use of DBS as a
viable  and low cost tool with greater operational capacity and
lower  risk of contamination in transport and storage.12,14 The
use  of easier to acquire equipment – sterile lancets and ﬁlter
paper  – compared to those used for serological standard proce-
dures  – syringes, tubes, centrifuges, refrigerators and freezers
–  is one advantage for tests conducted on ﬁlter paper.12–14
The use of this method of transporting blood in regions
at  a distance from large centres and by UBS teams, such as
those  from the PSF, may  increase access to serological tests,
through  a reduction in the turnaround time of results and the
possibility  of early intervention in the prevention of vertical
transmission. In fact, the average time elapsed between blood
collection  on ﬁlter paper and result availability at the Depart-
ment  of Health did not surpass 10 days. We  did not ﬁnd studies
that  assessed the time elapsed between the serological test
stages,  although Vieira and collaborators have described the
availability  of tests as a relevant factor for pregnant woman.10
Despite this gap, several studies have demonstrated an associ-
ation  between lower income, less schooling, indicators of less
accessibility  to laboratory tests, and the lowest percentage for
adequate PNC levels.1,2,4,5,9,10
In fact, it is reasonable to suppose that the process is more
expeditious when one uses the DBS methodology integrated
into  the system of dispatch, processing of and active search for
cases that fall within the UBS, USF, Laboratory Reference and
SDTs/AIDS  Care Centres. Additionally, a study conducted in
Bahia  to evaluate the heel prick test, demonstrated a median
time  of 35 days between birth and initiation of treatment for
children  with classical phenylketonuria.43
This study has certain limitations, such as the lack of evalu-
ation  of the ﬁnal result of the obtained diagnosis (conﬁrmation
of  treatment for the pregnant woman  and serological and clin-
ical screening for the newborn). Future investigations must be
carried out that consider the role of the SUS structural network
in  prenatal, birth and puerperium care, since works with this
focus  of analysis have found discrepant results.1,10,44Another limitation refers to the number of pregnant
women studied, since the obtained sample size was  inade-
quate  for the identiﬁcation of prevalence below 0.2%, which
may  explain the non-identiﬁcation of pregnant women  with
 2 0 1 
H
l
o
m
r
d
c
t
y
t
i
a
t
d
F
F
C
T
r
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2b r a z j i n f e c t d i s .
IV, since previous studies in Salvador have found a preva-
ence  of around 0.1% for this agent.26 Despite this, coverage
f  practically all the serological tests conducted in the
unicipality during the study period ensured the good rep-
esentativeness of the women  studied and the accuracy of the
ata.
We  may  therefore say that the infectious agents that cause
ongenital infections continue to be relevant in the Metropoli-
an  Region of Salvador, despite the decline observed in recent
ears.  The use of DBS represents a secure and viable alterna-
ive  to increase pregnant women’s access to serological tests
n  the prenatal period, strengthening the role played by an
ssociation  of this method with an active results informa-
ion  system and an active search for cases in order to reduce
iagnosis  the time elapsed and prevent vertical transmission.
unding
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